THE IMPACT OF EARLY CRYOBALLOON ABLATION ON CLINICAL OUTCOMES IN PATIENTS WITH NON-PAROXYSMAL ATRIAL FIBRILLATION

Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, the Second Hospital of Tianjin Medical University, Tianjin, China; School of Nursing and Health Sciences, Hong Kong

Cryoballoon ablation is recognized as a safe and effective rhythm control strategy for patients with atrial fibrillation (AF). The study focuses on the diagnosis-to-ablation time (DAT) as a predictor of outcomes, particularly the effects of early ablation within six months of diagnosis compared to delayed ablation. A cohort of patients was analyzed to determine differences in AF recurrence risk associated with the timing of the ablation procedure.